Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil
暂无分享,去创建一个
L. Bouzas | M. Flowers | N. Hamerschlak | L. Daudt | A. Seber | A. Vigorito | C. Bonfim | L. Ribeiro | R. Gouveia | V. Zecchin | J. Fernandes | R. Tavares | L. Arcuri | S. Nichele | C. de Souza Fernandez | N. Villela | Cinthya Corrêa da Silva | Carlos S Grecco | L. G. Darrigo-Jr | Simone Pereira Lermontov | Vergílio Coulturato | Paula Moreira da Silva | Priscila de Oliveira da Silva
[1] J. Wagner,et al. Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] J. Troy,et al. Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] J. Wagner,et al. Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] Shannon R. McCurdy,et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide , 2017, Haematologica.
[5] C. Craddock,et al. A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia , 2017, Journal of Hematology & Oncology.
[6] F. Locatelli,et al. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] D. McKenna,et al. Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] F. Appelbaum,et al. Cord-Blood Transplantation in Patients with Minimal Residual Disease. , 2016, The New England journal of medicine.
[9] M. Labopin,et al. Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings? , 2016, Leukemia.
[10] J. Wagner,et al. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[11] J. Wagner,et al. In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. , 2015, Biology of Blood and Marrow Transplantation.
[12] R. Porcher,et al. Impact of the source of hematopoietic stem cell in unrelated transplants: Comparison between 10/10, 9/10‐HLA matched donors and cord blood , 2015, American journal of hematology.
[13] H. Greinix,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .
[14] M. Konopleva,et al. Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] V. Boussiotis,et al. The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation. , 2014, Blood.
[16] J. Klein,et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. , 2014, Blood.
[17] M. Robin,et al. Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study , 2013, Bone Marrow Transplantation.
[18] J. Jacobson,et al. A comparison of immune reconstitution and graft‐versus‐host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients , 2011, British journal of haematology.
[19] D. Gao,et al. GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome , 2011, Bone Marrow Transplantation.
[20] R. Storb,et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. , 2011, Blood.
[21] Effie W Petersdorf,et al. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. , 2010, Blood.
[22] C. Spada,et al. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil. , 2010, Revista da Sociedade Brasileira de Medicina Tropical.
[23] J. Wagner,et al. Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[24] S. Feig,et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. , 2008, Blood.
[25] C. Walker,et al. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] J. Klein,et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.
[27] A. Nagler,et al. Umbilical cord blood transplantation--how, when and for whom? , 2004, Blood reviews.
[28] G. Stussi,et al. Graft‐versus‐host disease and survival after ABO‐incompatible allogeneic bone marrow transplantation: a single‐centre experience , 2001, British journal of haematology.
[29] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[30] A. S. Wiener,et al. Transplantation , 1963 .